Morphologic 3D scanning of fallopian tubes to assist ovarian cancer diagnosis

Pathological evaluation of the fallopian tubes is an important diagnostic result but tumors can be missed using routine approaches. As the majority of high-grade serous ovarian cancers are now believed to originate in the fallopian tubes, pathological examination should include in a thorough examination of the excised ovaries and fallopian tubes. We present an dedicated imaging system for diagnostic exploration of human fallopian tubes. This system is based on optical coherence tomography (OCT), a laser imaging modality giving access to sub- epithelial tissue architecture. This system produces cross-sectional images up to 3 mm in depth, with a lateral resolution of ≈15μm and an axial resolution of ≈12μm. An endoscopic single fiber probe was developed to fit in a human fallopian tube. This 1.2 mm probe produces 3D volume data of the entire inner tube within a few minutes. To demonstrate the clinical potential of OCT for lesion identification, we studied 5 different ovarian lesions and healthy fallopian tubes. We imaged 52 paraffin-embedded human surgical specimens with a benchtop system and compared these images with histology slides. We also imaged and compared healthy oviducts from 3 animal models to find one resembling the human anatomy and to develop a functional ex vivo imaging procedure with the endoscopic probe. We also present an update on an ongoing clinical pilot study on women undergoing prophylactic or diagnostic surgery in which we image ex vivo fallopian tubes with the endoscopic probe.

[1]  Ie-Ming Shih,et al.  The Origin and Pathogenesis of Epithelial Ovarian Cancer: A Proposed Unifying Theory , 2010, The American journal of surgical pathology.

[2]  C. MacAulay,et al.  Autofluorescence imaging can identify preinvasive or clinically occult lesions in fallopian tube epithelium: a promising step towards screening and early detection. , 2011, Gynecologic oncology.

[3]  F. Fakhrejahani,et al.  Symptoms of ovarian cancer in young patients 2 years before diagnosis, a case-control study. , 2008, European journal of cancer care.

[4]  D. Oram,et al.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial , 2016, The Lancet.

[5]  Vasilis Ntziachristos,et al.  Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo , 2011, Nature Medicine.

[6]  S. Kehoe,et al.  Symptoms associated with diagnosis of ovarian cancer: a systematic review , 2005, BJOG : an international journal of obstetrics and gynaecology.

[7]  D. Bell,et al.  Origins and molecular pathology of ovarian cancer , 2005, Modern Pathology.

[8]  A. Mes-Masson,et al.  Surgical implications of the potential new tubal pathway for ovarian carcinogenesis. , 2013, Journal of minimally invasive gynecology.

[9]  Nicolas Godbout,et al.  Molecular imaging needles: dual-modality optical coherence tomography and fluorescence imaging of labeled antibodies deep in tissue. , 2015, Biomedical optics express.

[10]  Pierre Lane,et al.  A high-efficiency fiber-based imaging system for co-registered autofluorescence and optical coherence tomography. , 2014, Biomedical optics express.

[11]  Christian Marth,et al.  2010 Gynecologic Cancer InterGroup (GCIG) Consensus Statement on Clinical Trials in Ovarian Cancer: Report From the Fourth Ovarian Cancer Consensus Conference , 2011, International Journal of Gynecologic Cancer.

[12]  Nicolas Godbout,et al.  Asymmetric double-clad fiber couplers for endoscopy. , 2013, Optics letters.

[13]  Stan B. Kaye,et al.  Imaging ovarian cancer and peritoneal metastases—current and emerging techniques , 2010, Nature Reviews Clinical Oncology.